REG - Spectra Systems Spectra Systems-SPSC - Exercise of Options and Total Voting Rights

Spectra SystemsAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260408:nRSH5356Za&default-theme=true

RNS Number : 5356Z  Spectra Systems Corporation  08 April 2026

 

 

Spectra Systems Corporation

 

(the "Company")

 

Exercise of Options and Total Voting Rights

 

Spectra Systems Corporation, a leader in machine-readable high speed banknote
authentication, brand protection technologies, and gaming security software,
announces the exercise of options by an employee of Spectra.

The employee has exercised options over 70,000 shares of common stock of $0.01
each in the Company ("Shares") with an exercise price of 25p per share on 30
March 2026. The employee has elected to pay the exercise price in cash.
Accordingly, the employee will be issued 70,000 shares.

The shares being issued are restricted securities as defined in Rule 144 of
the US Securities Act of 1933 and have been issued pursuant to an exemption
from registration under Rule 701 promulgated under the US Securities Act of
1933.

Accordingly, the Company has issued and will apply for 70,000 Shares to be
admitted to trading on AIM, which is expected to take place on or around 13
April 2026 ("Admission").

 

The Company's issued share capital now comprises:

 

612,258 shares in the Regulation S stock line ISIN number USU8457D1091
(AIM:SPSC); and

 

47,758,431 shares in the unrestricted line ISIN number US84756T1060
(AIM:SPSY).

 

Spectra Systems holds 20,000 Shares in treasury, therefore 48,350,689 may be
used by shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or a change
in their interest in, the share capital of the Company under the FCA's
Disclosure and Transparency Rules.

 

Enquiries:

 Spectra Systems Corporation                                                Tel: +1 (0)401 274 4700

 Dr. Nabil Lawandy, Chief Executive Officer
 Zeus (Nominated Adviser and Broker)                                        Tel: +44 (0)20 3829 5000

 James Joyce (Director)

 James Bavister (Assistant Director) Andrew de Andrade (Associate)

 Allenby Capital Limited (Joint Broker) Nick Naylor/James Reeve (Corporate  Tel: +44 (0)20 3328 5665
 Finance)

 Amrit Nahal (Sales and Corporate Broking)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEUPUACCUPQGMM



            Copyright 2019 Regulatory News Service, all rights reserved